Founded in 1913 with bleach as the sole product offering, Clorox (NYSE:CLX) today is a consumer products giant whose product portfolio spans everything from bleach to skincare to salad dressing to ...
With norovirus surging in New York, here's how to check if your cleaning products are effective at killing the stomach bug.
The Surface Disinfectant Market is experiencing significant growth driven by heightened hygiene awareness, the rise in healthcare-associated ... and eco-friendly products, exemplified by Diversey ...
Looking at the sectors faring worst as of midday Monday, shares of Consumer Products companies are underperforming ... The next worst performing sector is the Healthcare sector, showing a 0.9 ...
We’re fostering bolder ways of working that simplify operations and leverage technology to empower today’s workforce, all ...
Journal Editorial Report: The week's best and worst from Kim Strassel, Allysia Finley and Dan Henninger. Photo: Richard B. Levine/Lev Radin/Zuma Press Let’s imagine intelligent questions that ...
Bleach: Thousand-Year Blood War Part 4, titled The Calamity, is expected to air in early 2026. The final cour will feature never-before-seen scenes, surprising even manga readers. Tite Kubo is ...
Cardinal Health (CAH) is a global healthcare services and products company operating in the U.S., Canada, Europe, Asia and beyond. It offers solutions for hospitals, pharmacies, healthcare systems ...
Kyoraku has been holding his own against this powerful threat, and even seemed to bring the fight against Barro to an end with the full unleashing of his Bankai for the first real time in the anime.
Healthcare providers and IT vendors in the region have weighed in with their predictions for healthcare technology in the new year. A statistical analysis evaluated a refit of the Dementia AlgoRithm, ...
Google Cloud is at the forefront of AI. Though generative AI is a relatively new phenomenon, it seems like the technology is advancing at a whirlwind pace. Despite 2024 being an incredible year in ...
Currently, Aurobindo Pharma, Glenmark and Zydus are in the process of recalling their products in the US market due to manufacturing issues. While the concerns around Aurobindo Pharma and Glenmark ...